SEARCH:
Signup to create an account
test
Icahn Ups the Ante in Bid to Spin Off PayPal

Activist investor Carl Icahn upped the ante in its bid to push eBay Inc. (NASDAQ: EBAY) to spin off PayPal. In a DEF14A filing with the SEC, Mr. Icahn said that the complete disregard for accountability at eBay is the most blatant he's ever seen and strongly urged a number of changes designed to unlock value.

test
Two Ways to Invest in the Wireless Revolution

Most people thought Matt Rogers and Tony Fadell were crazy to leave Apple Inc. (NASDAQ: AAPL) in 2010 to try and start-up a small company focused on wireless home automation.


test
RXi Pharmaceuticals Moves Up to the NASDAQ Stock Exchange

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, has made a lot of progress.

Recent 8K Filings
OVERSEAS SHIPHOLDING GROUP INC
TRANSGLOBE ENERGY CORP
TELECOM ITALIA S P A
GENTOR RESOURCES INC.
CEL SCI CORP
3D SYSTEMS CORP
QR ENERGY, LP
PERMIAN BASIN ROYALTY TRUST
PLAINS ALL AMERICAN PIPELINE LP

Recent Insider Filings
THREE FORKS, INC. (NICHOLS W. EDWARD)
DIVERSIFIED RESTAURANT HOLDINGS, INC. (CURTIS JASON T.)
THREE FORKS, INC. (POLLARD CHARLES WILLIAM)
THREE FORKS, INC. (YOUNG WILLIAM F.)
SYNCHRONOSS TECHNOLOGIES INC (PRAGUE RONALD)
REX AMERICAN RESOURCES CORP (RIZVI ZAFAR A)
SYNCHRONOSS TECHNOLOGIES INC (WALDIS STEPHEN G)
FIRST BANCORP /PR/ (PANCHAM CASSAN)
SONOCO PRODUCTS CO (SAUNDERS BARRY L)



Executive Interview
Aethlon Medical (OTCQB: AEMD)
In this episode of the SECFilings.com Executive Interview Series we speak to Dr. Douglas Taylor, Chief Scientific Officer of Exosome Sciences, wholly owned subsidiary of Aethlon Medical.


Executive Interview
CrowdGather, Inc. (OTCQB: CRWG)
In this episode of the SECFilings.com TV Executive Interview Series we are joined by seasoned entrepreneur Sanjay Sabnani, Chief Executive Officer of CrowdGather, Inc.


Executive Interview
Galectin Therapeutics (NASDAQ: GALT)
In this SECFilings.com Executive Interview we speak with Mr. Jim Czirr, Executive Chairman of Galectin Therapeutics.



The page you have requested does not exist. We have recently renovated the website, so links from old email alerts may not work as intended. We thank you for your patience.